Results 171 to 180 of about 1,395,753 (295)
Transcriptomic imputation of genetic risk variants uncovers novel whole-blood biomarkers of Parkinson’s disease [PDF]
Gabriel Chew +7 more
openalex +1 more source
A mouse model for vascular normalization and a human breast cancer cohort were studied to understand the relationship between vascular leakage and tumor immune suppression. For this, endothelial and immune cell RNAseq, staining for vascular function, and immune cell profiling were employed.
Liqun He +8 more
wiley +1 more source
Genetic diseases underlying a spectrum of fetal effusions. [PDF]
Gulrajani NB +8 more
europepmc +1 more source
Analysis of the UCHL1 genetic variant in Parkinson's disease among Chinese
Eng‐King Tan +17 more
openalex +2 more sources
Liquid biopsy epigenetics: establishing a molecular profile based on cell‐free DNA
Cell‐free DNA (cfDNA) fragments in plasma from cancer patients carry epigenetic signatures reflecting their cells of origin. These epigenetic features include DNA methylation, nucleosome modifications, and variations in fragmentation. This review describes the biological properties of each feature and explores optimal strategies for harnessing cfDNA ...
Christoffer Trier Maansson +2 more
wiley +1 more source
Biomedical applications of organoids in genetic diseases. [PDF]
Huang W, Jeong S, Kim W, Chen L.
europepmc +1 more source
Identifying Families with Likely Genetic Protective Factors against Alzheimer Disease [PDF]
Jeremy Silverman +6 more
openalex +1 more source
Intein‐based modular chimeric antigen receptor platform for specific CD19/CD20 co‐targeting
CARtein is a modular CAR platform that uses split inteins to splice antigen‐recognition modules onto a universal signaling backbone, enabling precise, scarless assembly without re‐engineering signaling domains. Deployed here against CD19 and CD20 in B‐cell malignancies, the design supports flexible multi‐antigen targeting to boost T‐cell activation and
Pablo Gonzalez‐Garcia +9 more
wiley +1 more source

